MTOR and thyroid gland carcinoma: Combinations of vemurafenib and mTOR inhibitors should be further studied on human cancer xenografts on immunodeficient mice, to evaluate in vivo effects and potential clinical benefits for treatment of advanced thyroid cancer patients.